þ | Quarterly Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934 for the quarterly period Ended March 31, 2009. |
o | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from to |
Delaware | 76-0336636 | |
(State or other jurisdiction of | (IRS Employer | |
incorporation or organization) | Identification No.) | |
13403 Northwest Freeway, Houston, Texas | 77040-6094 | |
(Address of principal executive offices) | (Zip Code) |
Large accelerated filer þ | Accelerated filer o | Non-accelerated filer o | Smaller reporting company o | |||
(Do not check if a smaller reporting company) |
Page | ||||||||
Part I. FINANCIAL INFORMATION |
||||||||
Item 1. Financial Statements |
||||||||
5 | ||||||||
6 | ||||||||
7 | ||||||||
8 | ||||||||
9 | ||||||||
18 | ||||||||
31 | ||||||||
31 | ||||||||
33 | ||||||||
33 | ||||||||
33 | ||||||||
33 | ||||||||
34 | ||||||||
EX-31.1 | ||||||||
EX-31.2 | ||||||||
EX-32.1 |
2
| the effects of catastrophic losses, | ||
| the cyclical nature of the insurance business, | ||
| inherent uncertainties in the loss estimation process, which can adversely impact the adequacy of loss reserves, | ||
| the effects of emerging claim and coverage issues, | ||
| the effects of extensive governmental regulation of the insurance industry, | ||
| potential credit risk with brokers, | ||
| our assessment of underwriting risk, | ||
| our retention of risk, which could expose us to potential losses, | ||
| the adequacy of reinsurance protection, | ||
| the ability or willingness of reinsurers to pay balances due us, | ||
| the occurrence of terrorist activities, | ||
| our ability to maintain our competitive position, | ||
| changes in our assigned financial strength ratings, | ||
| our ability to raise capital and funds for liquidity in the future, | ||
| attraction and retention of qualified employees, | ||
| fluctuations in securities markets, which may reduce the value of our investment assets, reduce investment income or generate realized investment losses, | ||
| our ability to successfully expand our business through the acquisition of insurance-related companies, | ||
| impairment of goodwill, | ||
| the ability of our insurance company subsidiaries to pay dividends in needed amounts, | ||
| fluctuations in foreign exchange rates, |
3
| failures of our information technology systems, | ||
| potential changes to the countrys health care delivery system, and | ||
| change of control. |
4
March 31, | December 31, | |||||||
2009 | 2008 | |||||||
(as adjusted) | ||||||||
ASSETS |
||||||||
Investments: |
||||||||
Fixed income securities available for sale, at fair value (amortized cost: 2009
$4,168,329; 2008 $4,118,539) |
$ | 4,228,306 | $ | 4,133,165 | ||||
Fixed income securities held to maturity, at amortized cost (fair value: 2009 $95,432;
2008 $125,561) |
94,744 | 123,553 | ||||||
Short-term investments, at cost, which approximates fair value |
671,355 | 497,477 | ||||||
Other investments |
25,270 | 50,088 | ||||||
Total investments |
5,019,675 | 4,804,283 | ||||||
Cash |
33,013 | 27,347 | ||||||
Restricted cash and cash investments |
184,666 | 174,905 | ||||||
Premium, claims and other receivables |
807,177 | 770,823 | ||||||
Reinsurance recoverables |
1,078,532 | 1,054,950 | ||||||
Ceded unearned premium |
232,812 | 234,375 | ||||||
Ceded life and annuity benefits |
63,513 | 64,235 | ||||||
Deferred policy acquisition costs |
193,016 | 188,652 | ||||||
Goodwill |
862,658 | 858,849 | ||||||
Other assets |
148,855 | 153,581 | ||||||
Total assets |
$ | 8,623,917 | $ | 8,332,000 | ||||
LIABILITIES |
||||||||
Loss and loss adjustment expense payable |
$ | 3,490,033 | $ | 3,415,230 | ||||
Life and annuity policy benefits |
63,513 | 64,235 | ||||||
Reinsurance balances payable |
132,447 | 122,189 | ||||||
Unearned premium |
974,687 | 977,426 | ||||||
Deferred ceding commissions |
63,299 | 63,123 | ||||||
Premium and claims payable |
423,919 | 405,287 | ||||||
Notes payable |
424,714 | 343,649 | ||||||
Accounts payable and accrued liabilities |
346,395 | 300,838 | ||||||
Total liabilities |
5,919,007 | 5,691,977 | ||||||
SHAREHOLDERS EQUITY |
||||||||
Common stock, $1.00 par value; 250.0 million shares authorized (shares issued: 2009 116,743
and 2008 116,457; outstanding: 2009 112,070 and 2008 113,444) |
116,743 | 116,457 | ||||||
Additional paid-in capital |
888,121 | 881,534 | ||||||
Retained earnings |
1,746,943 | 1,677,831 | ||||||
Accumulated other comprehensive income |
51,902 | 27,536 | ||||||
Treasury stock, at cost (shares: 2009 4,673 and 2008 3,013) |
(98,799 | ) | (63,335 | ) | ||||
Total shareholders equity |
2,704,910 | 2,640,023 | ||||||
Total liabilities and shareholders equity |
$ | 8,623,917 | $ | 8,332,000 | ||||
5
Three months ended March 31, | ||||||||
2009 | 2008 | |||||||
(as adjusted) | ||||||||
REVENUE |
||||||||
Net earned premium |
$ | 502,388 | $ | 493,546 | ||||
Fee and commission income |
30,294 | 30,999 | ||||||
Net investment income |
45,218 | 47,621 | ||||||
Net realized investment gain (loss) |
(58 | ) | 168 | |||||
Other operating income (loss) |
22,896 | (4,946 | ) | |||||
Total revenue |
600,738 | 567,388 | ||||||
EXPENSE |
||||||||
Loss and loss adjustment expense, net |
315,566 | 293,026 | ||||||
Policy acquisition costs, net |
88,692 | 92,268 | ||||||
Other operating expense |
68,998 | 59,204 | ||||||
Interest expense |
4,639 | 4,953 | ||||||
Total expense |
477,895 | 449,451 | ||||||
Earnings before income tax expense |
122,843 | 117,937 | ||||||
Income tax expense |
39,673 | 37,482 | ||||||
Net earnings |
$ | 83,170 | $ | 80,455 | ||||
Earnings per common share: |
||||||||
Basic |
$ | 0.73 | $ | 0.70 | ||||
Diluted |
$ | 0.73 | $ | 0.69 | ||||
6
Accumulated | ||||||||||||||||||||||||
Additional | other | Total | ||||||||||||||||||||||
Common | paid-in | Retained | comprehensive | Treasury | shareholders | |||||||||||||||||||
stock | capital | earnings | income | stock | equity | |||||||||||||||||||
Balance at December 31, 2008
(as previously reported) |
$ | 116,457 | $ | 861,867 | $ | 1,696,816 | $ | 27,536 | $ | (63,335 | ) | $ | 2,639,341 | |||||||||||
Cumulative effect of
accounting change (adoption of
FSP APB 14-1) |
| 19,667 | (18,985 | ) | | | 682 | |||||||||||||||||
Balance at December 31, 2008
(as adjusted) |
116,457 | 881,534 | 1,677,831 | 27,536 | (63,335 | ) | 2,640,023 | |||||||||||||||||
Net earnings |
| | 83,170 | | | 83,170 | ||||||||||||||||||
Other comprehensive income |
| | | 24,366 | | 24,366 | ||||||||||||||||||
Comprehensive income |
107,536 | |||||||||||||||||||||||
Issuance of 126 shares for
exercise of options, including
tax charge of $428 |
126 | 1,964 | | | | 2,090 | ||||||||||||||||||
Purchase of 1,660 common shares |
| | | | (35,464 | ) | (35,464 | ) | ||||||||||||||||
Stock-based compensation |
160 | 4,623 | | | | 4,783 | ||||||||||||||||||
Cash dividends declared,
$0.125 per share |
| | (14,058 | ) | | | (14,058 | ) | ||||||||||||||||
Balance at March 31, 2009 |
$ | 116,743 | $ | 888,121 | $ | 1,746,943 | $ | 51,902 | $ | (98,799 | ) | $ | 2,704,910 | |||||||||||
7
Three months ended March 31, | ||||||||
2009 | 2008 | |||||||
(as adjusted) | ||||||||
Operating activities: |
||||||||
Net earnings |
$ | 83,170 | $ | 80,455 | ||||
Adjustments to reconcile net earnings to net cash provided by operating activities: |
||||||||
Change in premium, claims and other receivables |
(28,719 | ) | 3,779 | |||||
Change in reinsurance recoverables |
(29,973 | ) | 2,671 | |||||
Change in ceded unearned premium |
(217 | ) | 19,899 | |||||
Change in loss and loss adjustment expense payable |
67,544 | 91,845 | ||||||
Change in reinsurance balances payable |
11,481 | (5,761 | ) | |||||
Change in unearned premium |
(11,335 | ) | (16,960 | ) | ||||
Change in premium and claims payable, net of restricted cash |
8,859 | (45,449 | ) | |||||
Change in accounts payable and accrued liabilities |
(7,556 | ) | (7,015 | ) | ||||
Change in trading portfolio |
| 9,062 | ||||||
Stock-based compensation expense |
4,783 | 2,866 | ||||||
Depreciation and amortization expense |
3,579 | 3,390 | ||||||
Other, net |
31,986 | (2,982 | ) | |||||
Cash provided by operating activities |
133,602 | 135,800 | ||||||
Investing activities: |
||||||||
Sales of available for sale fixed income securities |
119,092 | 120,075 | ||||||
Maturity or call of available for sale fixed income securities |
69,280 | 75,875 | ||||||
Maturity or call of held to maturity fixed income securities |
85,821 | | ||||||
Cost of available for sale fixed income securities acquired |
(210,093 | ) | (419,238 | ) | ||||
Cost of held to maturity fixed income securities acquired |
(59,515 | ) | | |||||
Cost of other investments acquired |
| (36,735 | ) | |||||
Change in short-term investments |
(177,715 | ) | 128,052 | |||||
Proceeds from sales of other investments |
48,579 | 19,038 | ||||||
Payments for purchase of businesses, net of cash received |
(32,966 | ) | (71,486 | ) | ||||
Other, net |
(3,482 | ) | (1,670 | ) | ||||
Cash used by investing activities |
(160,999 | ) | (186,089 | ) | ||||
Financing activities: |
||||||||
Advances on line of credit |
80,000 | 40,000 | ||||||
Sale of common stock |
2,090 | 4,592 | ||||||
Purchase of common stock |
(35,464 | ) | | |||||
Dividends paid |
(14,182 | ) | (12,658 | ) | ||||
Other, net |
619 | 3,908 | ||||||
Cash provided by financing activities |
33,063 | 35,842 | ||||||
Net increase (decrease) in cash |
5,666 | (14,447 | ) | |||||
Cash at beginning of period |
27,347 | 39,135 | ||||||
Cash at end of period |
$ | 33,013 | $ | 24,688 | ||||
8
(1) | GENERAL INFORMATION | |
HCC Insurance Holdings, Inc. and its subsidiaries (collectively, we, us or our) include domestic and foreign property and casualty and life insurance companies, underwriting agencies and brokers. We provide specialized property and casualty, surety, and group life, accident and health insurance coverages and related agency and reinsurance brokerage services to commercial customers and individuals. We market our products both directly to customers and through a network of independent and affiliated brokers, producers, agents and third party administrators. Our lines of business include diversified financial products (which includes directors and officers liability, professional indemnity, employment practices liability, surety, credit, and fidelity coverages); group life, accident and health; aviation; our London market account (which includes energy, marine, property, and accident and health coverages); and other specialty lines of insurance (which includes event cancellation, contingency, public entity, U.K. liability, and other coverages). We operate primarily in the United States, the United Kingdom, Spain, Bermuda and Ireland, although some of our operations have a broader international scope. | ||
Basis of Presentation | ||
Our unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (generally accepted accounting principles) and include the accounts of HCC Insurance Holdings, Inc. and its subsidiaries. We have made all adjustments that, in our opinion, are necessary for a fair statement of results of the interim periods, and all such adjustments are of a normal recurring nature. All significant intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated financial statements should be read in conjunction with our annual audited consolidated financial statements and related notes. The condensed consolidated balance sheet at December 31, 2008 was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles. | ||
Management must make estimates and assumptions that affect amounts reported in our condensed consolidated financial statements and in disclosures of contingent assets and liabilities. Ultimate results could differ from those estimates. We have reclassified certain amounts in our 2008 condensed consolidated financial statements to conform to the 2009 presentation. None of our reclassifications had an effect on our consolidated net earnings, shareholders equity or cash flows. | ||
Accounting Pronouncements Adopted in 2009 | ||
FSP No. FAS 157-2, Effective Date of FASB Statement No. 157, became effective January 1, 2009. FSP FAS 157-2 requires prospective application of SFAS No. 157, Fair Value Measurements, to nonfinancial assets and nonfinancial liabilities measured at fair value on a nonrecurring basis. Our adoption of FSP FAS 157-2 had no impact on our condensed consolidated financial statements. | ||
SFAS No. 141 (revised 2007) (SFAS 141(R)), Business Combinations, and SFAS No. 160, Noncontrolling Interests in Consolidated Financial Statements, an amendment of Accounting Research Bulletin No. 51, became effective January 1, 2009. SFAS 141(R) changes certain accounting treatment for business combinations and impacts presentation of financial statements on the acquisition date and accounting for acquisitions in subsequent periods. SFAS 160 changes the accounting and reporting for minority interests, which are now recharacterized as noncontrolling interests and classified as a component of shareholders equity. Since January 1, 2009, we have recorded all new acquisitions under the guidance of SFAS 141(R). Our adoption of SFAS 160 had no impact on our condensed consolidated financial statements. | ||
SFAS No. 161, Disclosures about Derivative Instruments and Hedging Activities an amendment of FASB Statement No. 133, became effective January 1, 2009. SFAS 161 expands the required disclosures about a companys derivative and hedging activities. Our adoption had no impact on our condensed consolidated financial statements. | ||
FSP No. EITF 03-6-1, Determining Whether Instruments Granted in Share-Based Payment Transactions are Participating Securities, became effective January 1, 2009 and required retrospective application to prior periods. FSP EITF 03-6-1 clarifies whether instruments granted in share-based payments, such as restricted stock, are participating securities prior to vesting and, therefore, must be included in the earnings allocation in calculating earnings per share under the two-class method described in SFAS No. 128, Earnings per Share. Under FSP EITF 03-6-1, unvested share-based payments that contain non-forfeitable rights to dividends or dividend-equivalents are treated as participating securities. Our adoption of FSP EITF 03-6-1 had no material impact on our consolidated earnings per share in any period due to immateriality of our restricted stock awards that have such terms. |
9
FSP No. APB 14-1, Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement) became effective January 1, 2009, required retrospective application to prior financial statements and did not permit early adoption. FSP APB 14-1 clarifies that convertible debt instruments that may be settled in cash upon conversion are not totally debt and requires issuers to bifurcate and separately account for the liability and equity components. In our condensed consolidated financial statements, we adopted FSP APB 14-1 for our 1.30% Convertible Notes and 2.00% Convertible Notes and retrospectively adjusted our consolidated financial statements for all periods prior to 2009. The effective interest rate on our 1.30% and 2.00% Convertible Notes increased to 4.80% and 3.86%, respectively, which resulted in the recognition of a $22.6 million and $8.3 million discount, respectively, with the offsetting after-tax impact recorded in additional paid-in capital. The following line items in our condensed consolidated financial statements were affected by this change in accounting principle: |
Three months ended March 31, 2008 | ||||||||||||
As originally | ||||||||||||
reported | As adjusted | Change | ||||||||||
Interest expense |
$ | 3,959 | $ | 4,953 | $ | 994 | ||||||
Earnings before income tax expense |
118,931 | 117,937 | (994 | ) | ||||||||
Income tax expense |
37,830 | 37,482 | (348 | ) | ||||||||
Net earnings |
81,101 | 80,455 | (646 | ) | ||||||||
Diluted earnings per share |
0.70 | 0.69 | (0.01 | ) |
December 31, 2008 | ||||||||||||
As originally | ||||||||||||
reported | As adjusted | Change | ||||||||||
Other assets (debt issuance costs and deferred tax asset) |
$ | 153,964 | $ | 153,581 | $ | (383 | ) | |||||
Notes payable |
344,714 | 343,649 | (1,065 | ) | ||||||||
Additional paid-in capital |
861,867 | 881,534 | 19,667 | |||||||||
Retained earnings |
1,696,816 | 1,677,831 | (18,985 | ) | ||||||||
Total shareholders equity |
2,639,341 | 2,640,023 | 682 |
The reduction in retained earnings and the increase in additional paid-in capital resulted from amortization of the implied discount as interest expense through the first contractual put date of the 2.00% Convertible Notes at September 1, 2007 and the 1.30% Convertible Notes at April 1, 2009. The 2.00% Convertible Notes were submitted for conversion during September and October 2007. At March 31, 2009, the implied discount on the 1.30% Convertible Notes was fully amortized, there was no remaining equity component, and the liability component was $124.7 million. At December 31, 2008, the 1.30% Convertible Notes had an equity component of $1.1 million and a liability component of $123.6 million, consisting of a principal amount of $124.7 million less a discount of $1.1 million. The effective interest rate on our 1.30% Convertible Notes was 4.80% for the three months ended March 31, 2009 and 2008. The contractual interest expense was $0.4 million in the first quarter of 2009 and 2008. Interest expense resulting from amortization of the implied discount was $1.1 million and $1.0 million in the three months ended March 31, 2009 and 2008, respectively. The adoption of FSP APB 14-1 did not impact our past or current consolidated cash flows. | ||
Our 1.30% Convertible Notes are due in 2023. We pay interest semi-annually on April 1 and October 1. Each one thousand dollar principal amount of notes is convertible into 44.1501 shares of our common stock, which represents an initial conversion price of $22.65 per share. The initial conversion price is subject to standard anti-dilution provisions designed to maintain the value of the conversion option in the event we take certain actions with respect to our common stock, such as stock splits, reverse stock splits, stock dividends and extraordinary dividends, that affect all of the holders of our common stock equally and that could have a dilutive effect on the value of the conversion rights of the holders of the notes or that confer a benefit upon our current shareholders not otherwise available to the 1.30% Convertible Notes. Holders may surrender notes for conversion if, as of the last day of the preceding calendar quarter, the closing sale price of our common stock for at least 20 consecutive trading days during the period of 30 consecutive trading days ending on the last trading day of that quarter is more than 130% ($29.45 per share) of the conversion price per share of our common stock. This condition was not met at March 31, 2009. While the notes are not convertible during the |
10
second quarter of 2009, the convertible value of the notes, if converted, at March 31, 2009 was $138.7 million, which exceeds the principal amount by $14.0 million. We must settle any conversions by paying cash for the principal amount of the notes and issuing our common stock for the value of the conversion premium. We can redeem the notes for cash at any time. Holders may require us to repurchase the notes on April 1, 2014 or 2019. The repurchase price to settle any such put by the holders will equal the principal amount of the notes plus accrued and unpaid interest and will be paid in cash. | ||
Recent Accounting Pronouncements | ||
The FASB has issued FSP FAS 157-4, Determining Fair Value When the Volume and Level of Activity for the Asset or Liability Have Significantly Decreased and Identifying Transactions that Are Not Orderly, and FSP FAS 107-1 and APB 28-1, Interim Disclosures about Fair Value of Financial Instruments. These two standards modify the accounting guidance for determining fair value of financial statements under distressed market conditions and expand the related disclosures. The FASB has also issued FSP FAS 115-2 and FAS 124-2, Recognition and Presentation of Other-Than-Temporary Impairments. This standard revises the recognition and measurement requirements for impairment losses on debt securities and expands the related disclosures. We must adopt all three FSPs for the quarter ending June 30, 2009. Based on past results of our investment portfolio and its composition at March 31, 2009, we do not expect adoption of the FSPs to have a material effect on our consolidated financial statements. | ||
Acquisition | ||
On February 27, 2009, we acquired Surety Company of the Pacific, which writes license and permit bonds for California contractors. We included the results of operations of the acquired company in our condensed consolidated financial statements beginning on March 1, 2009. We valued all identifiable assets and liabilities at fair value, in accordance with SFAS 141(R). We are waiting for completion of an independent audit of the sellers financial statements to complete the valuation of certain assets and liabilities required for our final purchase price allocation. We allocated $0.8 million to goodwill in our initial purchase price allocation. The goodwill is not deductible for United States Federal income tax purposes. | ||
Income Tax | ||
For the three months ended March 31, 2009 and 2008, the income tax provision was calculated based on an estimated effective tax rate for each fiscal year. Our effective tax rate differs from the United States Federal statutory rate primarily due to tax-exempt municipal bond interest. | ||
Stock-Based Compensation | ||
In the first quarter of 2009, we granted the following shares of common stock, restricted stock, restricted stock units and stock options for the purchase of shares of our common stock. The fair value of the common stock was expensed on the grant date. The fair value of the restricted stock, restricted stock units and stock options will be expensed over the vesting period. |
Weighted-average | ||||||||||||||||
Number of | grant date | Aggregate | Vesting | |||||||||||||
shares | fair value | fair value | period | |||||||||||||
Common stock |
48 | $ | 23.94 | $ | 1,138 | | ||||||||||
Restricted stock |
112 | 24.00 | 2,696 | 3-4 years | ||||||||||||
Restricted stock units |
18 | 23.94 | 429 | 4 years | ||||||||||||
Stock options |
140 | 24.26 | 685 | 3-5 years |
11
(2) | FAIR VALUE | |
In accordance with SFAS No. 157, Fair Value Measurements, we value financial assets and financial liabilities at fair value. In determining fair value, we generally apply the market approach, which uses prices and other relevant data based on market transactions involving identical or comparable assets and liabilities. We classify our financial instruments into the following three-level hierarchy established by SFAS 157: |
| Level 1 Inputs are based on quoted prices in active markets for identical instruments. | ||
| Level 2 Inputs are based on observable market data (other than quoted prices), or are derived from or corroborated by observable market data. | ||
| Level 3 Inputs are unobservable and not corroborated by market data. |
Our Level 1 investments are primarily U.S. Treasuries, for which we use quoted prices for identical instruments to measure fair value. | ||
Our Level 2 investments include most of our fixed income securities, which consist of U.S. government agency securities, municipal bonds, certain corporate debt securities, and certain mortgage and asset-backed securities. Our Level 2 instruments also include our interest rate swap agreements, which were reflected as liabilities in our consolidated balance sheet at March 31, 2009. We measure fair value for the majority of our Level 2 investments using quoted prices of securities with similar characteristics. The remaining investments are valued using pricing models or matrix pricing. The fair value measurements consider observable assumptions, including benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, default rates, loss severity and other economic measures. | ||
We use independent pricing services to assist us in determining fair value for over 99% of our Level 1 and Level 2 investments. We use data provided by our third party investment managers to value the remaining Level 2 investments. No markets for our investments were judged to be inactive. To validate quoted and modeled prices, we perform various procedures, including evaluation of the underlying methodologies, analysis of recent sales activity, and analytical review of our fair values against current market prices, other pricing services and historical trends. | ||
Our Level 3 financial instruments include certain fixed income securities and two insurance contracts that we account for as derivatives. We determine fair value based on internally developed models that use assumptions or other data that are not readily observable from objective sources. Because we use the lowest level significant input to determine our hierarchy classifications, a financial instrument may be classified in Level 3 even though there may be significant readily-observable inputs. | ||
We excluded from our SFAS 157 disclosures certain assets, such as alternative investments and certain strategic investments in insurance-related companies, since we account for them using the equity method of accounting and have not elected to measure them at fair value. These assets had a recorded value of $35.2 million at March 31, 2009. We also excluded our held to maturity investment portfolio valued at $94.7 million and an investment valued at $4.1 million at March 31, 2009, which are measured at amortized cost and at cost, respectively. | ||
The following table presents our assets and interest rate swap liabilities that were measured at fair value as of March 31, 2009. |
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Fixed income securities |
$ | 75,839 | $ | 4,147,382 | $ | 5,085 | $ | 4,228,306 | ||||||||
Other investments |
14 | | | 14 | ||||||||||||
Other assets |
| | 16,463 | 16,463 | ||||||||||||
Total assets measured at fair value |
$ | 75,853 | $ | 4,147,382 | $ | 21,548 | $ | 4,244,783 | ||||||||
Accounts payable and accrued liabilities |
$ | | $ | (6,951 | ) | $ | | $ | (6,951 | ) | ||||||
Total liabilities measured at fair value |
$ | | $ | (6,951 | ) | $ | | $ | (6,951 | ) | ||||||
12
The following table presents the changes in fair value of our Level 3 category during the first quarter of 2009. |
Fixed | ||||||||||||
income | Other | |||||||||||
securities | assets | Total | ||||||||||
Balance at December 31, 2008 |
$ | 6,515 | $ | 16,100 | $ | 22,615 | ||||||
Net redemptions |
(281 | ) | | (281 | ) | |||||||
Gains and (losses) unrealized |
567 | 363 | 930 | |||||||||
Gains and (losses) realized |
30 | | 30 | |||||||||
Net transfers out of Level 3 |
(1,746 | ) | | (1,746 | ) | |||||||
Balance at March 31, 2009 |
$ | 5,085 | $ | 16,463 | $ | 21,548 | ||||||
Unrealized gains and losses on our Level 3 fixed income securities are reported in other comprehensive income within shareholders equity, and unrealized gains and losses on our Level 3 other assets are reported in other operating income. We transferred investments from Level 3 to Level 2 because we were able to determine their fair value using inputs based on observable market data at March 31, 2009. | ||
(3) | REINSURANCE | |
In the normal course of business, our insurance companies cede a portion of their premium to domestic and foreign reinsurers through treaty and facultative reinsurance agreements. Although ceding for reinsurance purposes does not discharge the direct insurer from liability to its policyholder, our insurance companies participate in such agreements in order to limit their loss exposure, protect them against catastrophic loss and diversify their business. The following table presents the effect of such reinsurance transactions on our premium and loss and loss adjustment expense. |
Loss and loss | ||||||||||||
Written | Earned | adjustment | ||||||||||
premium | premium | expense | ||||||||||
Three months ended March 31, 2009 | ||||||||||||
Direct business |
$ | 532,032 | $ | 549,037 | $ | 362,270 | ||||||
Reinsurance assumed |
70,355 | 64,140 | 36,665 | |||||||||
Reinsurance ceded |
(111,137 | ) | (110,789 | ) | (83,369 | ) | ||||||
Net amounts |
$ | 491,250 | $ | 502,388 | $ | 315,566 | ||||||
Three months ended March 31, 2008 | ||||||||||||
Direct business |
$ | 483,146 | $ | 511,623 | $ | 292,811 | ||||||
Reinsurance assumed |
99,853 | 93,070 | 69,272 | |||||||||
Reinsurance ceded |
(89,352 | ) | (111,147 | ) | (69,057 | ) | ||||||
Net amounts |
$ | 493,647 | $ | 493,546 | $ | 293,026 | ||||||
Ceding commissions that are netted against policy acquisition costs in the condensed consolidated statements of earnings were $12.5 million in 2009 and $11.7 million in 2008. | ||
The table below shows the components of reinsurance recoverables in our condensed consolidated balance sheets. |
March 31, | December 31, | |||||||
2009 | 2008 | |||||||
Reinsurance recoverable on paid losses |
$ | 66,418 | $ | 64,419 | ||||
Reinsurance recoverable on outstanding losses |
576,304 | 535,563 | ||||||
Reinsurance recoverable on incurred but not reported losses |
441,254 | 463,396 | ||||||
Reserve for uncollectible reinsurance |
(5,444 | ) | (8,428 | ) | ||||
Total reinsurance recoverables |
$ | 1,078,532 | $ | 1,054,950 | ||||
13
Our reserve for uncollectible reinsurance covers potential collectibility issues, including disputed amounts and associated expenses. While we believe the reserve is adequate based on information currently available, market conditions may change or additional information might be obtained that may require us to change the reserve in the future. We periodically review our financial exposure to the reinsurance market and the level of our reserve and continue to take actions in an attempt to mitigate our exposure to possible loss. | ||
Reinsurers not authorized by the respective states of our U.S. domiciled insurance companies are required to collateralize reinsurance obligations due to us. The table below shows the amounts of letters of credit and cash deposits held by us as collateral, plus other credits available for potential offset. |
March 31, | December 31, | |||||||
2009 | 2008 | |||||||
Payables to reinsurers |
$ | 252,779 | $ | 252,198 | ||||
Letters of credit |
199,254 | 184,314 | ||||||
Cash deposits |
105,923 | 110,153 | ||||||
Total credits |
$ | 557,956 | $ | 546,665 | ||||
The tables below present the calculation of net reserves, net unearned premium and net deferred policy acquisition costs. |
March 31, | December 31, | |||||||
2009 | 2008 | |||||||
Loss and loss adjustment expense payable |
$ | 3,490,033 | $ | 3,415,230 | ||||
Reinsurance recoverable on outstanding losses |
(576,304 | ) | (535,563 | ) | ||||
Reinsurance recoverable on incurred but not reported losses |
(441,254 | ) | (463,396 | ) | ||||
Net reserves |
$ | 2,472,475 | $ | 2,416,271 | ||||
Unearned premium |
$ | 974,687 | $ | 977,426 | ||||
Ceded unearned premium |
(232,812 | ) | (234,375 | ) | ||||
Net unearned premium |
$ | 741,875 | $ | 743,051 | ||||
Deferred policy acquisition costs |
$ | 193,016 | $ | 188,652 | ||||
Deferred ceding commissions |
(63,299 | ) | (63,123 | ) | ||||
Net deferred policy acquisition costs |
$ | 129,717 | $ | 125,529 | ||||
(4) | EARNINGS PER SHARE | |
The following table details the numerator and denominator used in our earnings per share calculations. |
Three months ended March 31, | ||||||||
2009 | 2008 | |||||||
(as adjusted) | ||||||||
Net earnings |
$ | 83,170 | $ | 80,455 | ||||
Less: net earnings attributable to unvested restricted stock and restricted stock units |
(396 | ) | (2 | ) | ||||
Net earnings attributable to common stock |
$ | 82,774 | $ | 80,453 | ||||
Weighted-average common shares outstanding |
112,799 | 115,232 | ||||||
Dilutive effect of outstanding options (determined using treasury stock method) |
235 | 532 | ||||||
Dilutive effect of convertible debt (determined using treasury stock method) |
255 | 605 | ||||||
Weighted-average common shares and potential common shares outstanding |
113,289 | 116,369 | ||||||
Anti-dilutive stock options not included in treasury stock method computation |
6,509 | 5,622 | ||||||
14
(5) | SEGMENT AND GEOGRAPHIC DATA | |
The performance of each segment is evaluated by our management based on net earnings. Net earnings is calculated after corporate expense allocations, interest expense on debt incurred for acquired companies, and intercompany eliminations have been charged or credited to our individual segments. All stock-based compensation is included in the corporate segment because it is not included in managements evaluation of the other segments. All contractual and discretionary bonuses are expensed in the respective employees segment in the year the bonuses are earned. Any such bonuses that will be paid by restricted stock awards, which will be granted by the Compensation Committee in the following year, are reversed in the corporate segment, which, in turn, will record the appropriate stock-based compensation expense as the awards vest in future years. | ||
The following tables show information by business segment and geographic location. Geographic location is determined by physical location of our offices and does not represent the location of insureds or reinsureds from whom the business was generated. |
Insurance | Other | |||||||||||||||||||
Company | Agency | Operations | Corporate | Total | ||||||||||||||||
Three months ended March 31, 2009 |
||||||||||||||||||||
Revenue: |
||||||||||||||||||||
Domestic |
$ | 470,386 | $ | 18,010 | $ | 2,278 | $ | 652 | $ | 491,326 | ||||||||||
Foreign |
103,103 | 6,309 | | | 109,412 | |||||||||||||||
Inter-segment |
| 23,747 | 254 | | 24,001 | |||||||||||||||
Total segment revenue |
$ | 573,489 | $ | 48,066 | $ | 2,532 | $ | 652 | 624,739 | |||||||||||
Inter-segment eliminations |
(24,001 | ) | ||||||||||||||||||
Consolidated total revenue |
$ | 600,738 | ||||||||||||||||||
Net earnings (loss): |
||||||||||||||||||||
Domestic |
$ | 69,913 | $ | 3,161 | $ | 1,013 | $ | (7,606 | ) | $ | 66,481 | |||||||||
Foreign |
16,002 | 215 | | | 16,217 | |||||||||||||||
Total segment net earnings (loss) |
$ | 85,915 | $ | 3,376 | $ | 1,013 | $ | (7,606 | ) | 82,698 | ||||||||||
Inter-segment eliminations |
472 | |||||||||||||||||||
Consolidated net earnings |
$ | 83,170 | ||||||||||||||||||
Other items: |
||||||||||||||||||||
Net investment income |
$ | 44,220 | $ | 210 | $ | 4 | $ | 784 | $ | 45,218 | ||||||||||
Depreciation and amortization |
1,126 | 1,747 | 22 | 684 | 3,579 | |||||||||||||||
Interest expense (benefit) |
279 | 3,734 | (7 | ) | 633 | 4,639 | ||||||||||||||
Capital expenditures |
496 | 2,088 | 10 | 888 | 3,482 | |||||||||||||||
Tax expense: |
||||||||||||||||||||
Income tax expense (benefit) |
$ | 38,236 | $ | 3,376 | $ | 589 | $ | (2,479 | ) | $ | 39,722 | |||||||||
Inter-segment eliminations |
(49 | ) | ||||||||||||||||||
Consolidated income tax expense |
$ | 39,673 | ||||||||||||||||||
15
Insurance | Other | |||||||||||||||||||
Company | Agency | Operations | Corporate | Total | ||||||||||||||||
Three months ended March 31, 2008 (as adjusted) |
||||||||||||||||||||
Revenue: |
||||||||||||||||||||
Domestic |
$ | 456,928 | $ | 13,951 | $ | (6,245 | ) | $ | 332 | $ | 464,966 | |||||||||
Foreign |
92,697 | 9,725 | | | 102,422 | |||||||||||||||
Inter-segment |
| 17,109 | | | 17,109 | |||||||||||||||
Total segment revenue |
$ | 549,625 | $ | 40,785 | $ | (6,245 | ) | $ | 332 | 584,497 | ||||||||||
Inter-segment eliminations |
(17,109 | ) | ||||||||||||||||||
Consolidated total revenue |
$ | 567,388 | ||||||||||||||||||
Net earnings (loss): |
||||||||||||||||||||
Domestic |
$ | 66,730 | $ | 4,685 | $ | (5,080 | ) | $ | (8,313 | ) | $ | 58,022 | ||||||||
Foreign |
20,856 | 421 | | | 21,277 | |||||||||||||||
Total segment net earnings (loss) |
$ | 87,586 | $ | 5,106 | $ | (5,080 | ) | $ | (8,313 | ) | 79,299 | |||||||||
Inter-segment eliminations |
1,156 | |||||||||||||||||||
Consolidated net earnings |
$ | 80,455 | ||||||||||||||||||
Other items: |
||||||||||||||||||||
Net investment income |
$ | 45,756 | $ | 1,553 | $ | 17 | $ | 295 | $ | 47,621 | ||||||||||
Depreciation and amortization |
1,181 | 1,491 | 35 | 683 | 3,390 | |||||||||||||||
Interest expense (benefit) |
131 | 2,506 | (26 | ) | 2,342 | 4,953 | ||||||||||||||
Capital expenditures |
651 | 1,228 | 2 | 779 | 2,660 | |||||||||||||||
Tax expense: |
||||||||||||||||||||
Income tax expense (benefit) |
$ | 38,570 | $ | 3,545 | $ | (3,711 | ) | $ | (1,628 | ) | $ | 36,776 | ||||||||
Inter-segment eliminations |
706 | |||||||||||||||||||
Consolidated income tax expense |
$ | 37,482 | ||||||||||||||||||
Three months ended March 31, | ||||||||
2009 | 2008 | |||||||
Diversified financial products |
$ | 214,084 | $ | 192,177 | ||||
Group life, accident and health |
201,088 | 192,446 | ||||||
Aviation |
32,814 | 34,993 | ||||||
London market account |
23,674 | 27,090 | ||||||
Other specialty lines |
30,724 | 46,846 | ||||||
Discontinued lines |
4 | (6 | ) | |||||
Net earned premium |
$ | 502,388 | $ | 493,546 | ||||
Property and casualty |
$ | 24,418 | $ | 25,254 | ||||
Accident and health |
5,876 | 5,745 | ||||||
Fee and commission income |
$ | 30,294 | $ | 30,999 | ||||
16
(6) | SUPPLEMENTAL INFORMATION | |
Supplemental cash flow information was as follows: |
Three months ended March 31, | ||||||||
2009 | 2008 | |||||||
(as adjusted) | ||||||||
Income taxes paid |
$ | 20,214 | $ | 16,111 | ||||
Interest paid |
3,442 | 4,091 | ||||||
Comprehensive income |
107,536 | 86,407 |
(7) | COMMITMENTS AND CONTINGENCIES | |
Litigation | ||
We are a party to lawsuits, arbitrations and other proceedings that arise in the normal course of our business. Many of such lawsuits, arbitrations and other proceedings involve claims under policies that we underwrite as an insurer or reinsurer, the liabilities for which, we believe, have been adequately included in our loss reserves. Also, from time to time, we are a party to lawsuits, arbitrations and other proceedings that relate to disputes with third parties, or that involve alleged errors and omissions on the part of our subsidiaries. We have provided accruals for these items to the extent we deem the losses probable and reasonably estimable. Although the ultimate outcome of these matters cannot be determined at this time, based on present information, the availability of insurance coverage and advice received from our outside legal counsel, we believe the resolution of any such matters will not have a material adverse effect on our consolidated financial position, results of operations or cash flows. | ||
Indemnifications | ||
In conjunction with the sales of business assets and subsidiaries, we have provided indemnifications to the buyers. Certain indemnifications cover typical representations and warranties related to our responsibilities to perform under the sales contracts. Under other indemnifications, we agree to reimburse the purchasers for taxes or ERISA-related amounts, if any, assessed after the sale date but related to pre-sale activities. We cannot quantify the maximum potential exposure covered by all of our indemnifications because the indemnifications cover a variety of matters, operations and scenarios. Certain of these indemnifications have no time limit. For those with a time limit, the longest such indemnification expires on December 31, 2009. We accrue a loss when a valid claim is made by a purchaser and we believe we have potential exposure. At March 31, 2009, we have recorded a liability of $15.3 million and have provided $6.7 million of letters of credit to cover our obligations or anticipated payments under these indemnifications. |
17
| risk-bearing earned premium produced by our insurance companies operations, | ||
| non-risk-bearing fee and commission income received by our underwriting agencies and brokers, | ||
| ceding commissions in excess of policy acquisition costs earned by our insurance companies, | ||
| investment income earned by all of our operations, | ||
| realized investment gains and losses related to our fixed income securities portfolio, and | ||
| other operating income and losses, mainly from strategic investments and events that do not occur each year. |
18
Three months ended March 31, | ||||||||
2009 | 2008 | |||||||
Pretax earnings (loss) from: |
||||||||
Commutation of reinsurance contract, net of related costs |
$ | 15,600 | $ | | ||||
Prior years positive (adverse) reserve development |
(4,727 | ) | 5,127 | |||||
Other-than-temporary impairments of fixed income securities |
(3,113 | ) | | |||||
Trading securities |
| (9,028 | ) |
| In 2009, we commuted all liability loss-free under a contract to provide reinsurance coverage for certain residential mortgage guaranty contracts. We had been recording revenue under this contract using the deposit method of accounting because we determined the contract did not transfer significant underwriting risk. We received a cash termination payment of $25.0 million in the quarter. The termination increased other operating income by $20.5 million and fee and commission income by $5.0 million. This revenue was offset by $9.9 million of expenses for reinsurance and other direct costs. The expenses were recorded in other operating expense in the first quarter of 2009. | |
| In 2009, we had adverse development of our prior years net loss reserves of $4.7 million, primarily from reserve increases in certain of our group life, accident and health businesses. We had favorable development of $5.1 million in 2008 primarily from the re-estimation of our net exposure on certain case basis reserves. | |
| We recognized other-than-temporary impairments on securities in our available for sale fixed income securities portfolio of $3.1 million in 2009, which we recorded in net realized investment loss. Our 2009 impairment losses were offset by gains on investments sold in the quarter. There were no other-than-temporary impairments recorded in 2008. | |
| Our trading portfolio, which we liquidated during 2008, had fair value losses of $9.0 million in the first three months of 2008. These losses are reported in other operating income (loss). |
19
Three months ended March 31, | ||||||||
2009 | 2008 | |||||||
(as adjusted) | ||||||||
Net earned premium |
83.6 | % | 87.0 | % | ||||
Fee and commission income |
5.0 | 5.5 | ||||||
Net investment income |
7.5 | 8.4 | ||||||
Other operating income (loss) |
3.9 | (0.9 | ) | |||||
Total revenue |
100.0 | 100.0 | ||||||
Loss and loss adjustment expense, net |
52.5 | 51.6 | ||||||
Policy acquisition costs, net |
14.8 | 16.3 | ||||||
Other operating expense |
11.5 | 10.4 | ||||||
Interest expense |
0.8 | 0.9 | ||||||
Earnings before income tax expense |
20.4 | 20.8 | ||||||
Income tax expense |
6.6 | 6.6 | ||||||
Net earnings |
13.8 | % | 14.2 | % | ||||
Three months ended March 31, | ||||||||
2009 | 2008 | |||||||
Gross written premium |
$ | 602,387 | $ | 582,999 | ||||
Net written premium |
491,250 | 493,647 | ||||||
Net earned premium |
502,388 | 493,546 |
Three months ended March 31, | ||||||||
2009 | 2008 | |||||||
Agencies |
$ | 24,576 | $ | 22,284 | ||||
Insurance companies |
5,718 | 8,715 | ||||||
Fee and commission income |
$ | 30,294 | $ | 30,999 | ||||
Three months ended March 31, | ||||||||
2009 | 2008 | |||||||
Fixed income securities |
||||||||
Taxable |
$ | 25,105 | $ | 22,452 | ||||
Exempt from U.S. income taxes |
20,333 | 18,472 | ||||||
Total fixed income securities |
45,438 | 40,924 | ||||||
Short-term investments |
1,794 | 8,592 | ||||||
Alternative investments |
(962 | ) | (1,205 | ) | ||||
Other investments |
| 267 | ||||||
Total investment income |
46,270 | 48,578 | ||||||
Investment expense |
(1,052 | ) | (957 | ) | ||||
Net investment income |
$ | 45,218 | $ | 47,621 | ||||
20
Three months ended March 31, | ||||||||
2009 | 2008 | |||||||
Contract using deposit accounting |
$ | 20,532 | $ | | ||||
Trading securities |
| (9,028 | ) | |||||
Strategic investments |
750 | 913 | ||||||
Financial instruments |
363 | 1,336 | ||||||
Other |
1,251 | 1,833 | ||||||
Other operating income (loss) |
$ | 22,896 | $ | (4,946 | ) | |||
21
Gross | Net | NWP | Net | |||||||||||||
written | written | as % of | earned | |||||||||||||
premium | premium | GWP | premium | |||||||||||||
Three months ended March 31, 2009 |
||||||||||||||||
Diversified financial products |
$ | 245,112 | $ | 203,363 | 83 | % | $ | 214,084 | ||||||||
Group life, accident and health |
216,993 | 199,056 | 92 | 201,088 | ||||||||||||
Aviation |
41,952 | 30,611 | 73 | 32,814 | ||||||||||||
London market account |
44,749 | 26,394 | 59 | 23,674 | ||||||||||||
Other specialty lines |
53,577 | 31,822 | 59 | 30,724 | ||||||||||||
Discontinued lines |
4 | 4 | nm | 4 | ||||||||||||
Totals |
$ | 602,387 | $ | 491,250 | 82 | % | $ | 502,388 | ||||||||
Three months ended March 31, 2008 |
||||||||||||||||
Diversified financial products |
$ | 211,364 | $ | 180,501 | 85 | % | $ | 192,177 | ||||||||
Group life, accident and health |
210,534 | 202,375 | 96 | 192,446 | ||||||||||||
Aviation |
44,828 | 32,346 | 72 | 34,993 | ||||||||||||
London market account |
40,936 | 29,028 | 71 | 27,090 | ||||||||||||
Other specialty lines |
75,343 | 49,403 | 66 | 46,846 | ||||||||||||
Discontinued lines |
(6 | ) | (6 | ) | nm | (6 | ) | |||||||||
Totals |
$ | 582,999 | $ | 493,647 | 85 | % | $ | 493,546 | ||||||||
nm Not meaningful |
| Diversified financial products Gross and net written premium increased because we wrote more domestic directors and officers liability business at higher prices in 2009 and generated additional premium from title insurance and new lines of business. Premium volume in our other major products in this group was stable, although pricing for certain of these products is down slightly. Earned premium increased in 2009 for the same reasons. Our retention rate was lower because we are reinsuring more directors and officers liability business in 2009. | ||
| Group life, accident and health The increase in gross written premium was due to writing more sports disability business, which is substantially reinsured. The premium increase from a company acquired in late 2008 was offset by lower premium in our organic lines of business. The increase in net earned premium was due to our acquisition of MultiNational Underwriters in the first quarter of 2008. |
22
| Aviation Our aviation premium volume was essentially flat due to continuing competition and lack of growth in the aviation industry. Pricing on this line remains competitive, although we have seen price increases on the international portion of this business. | ||
| London market account Gross written premium was higher and our retention rate was lower in 2009 due to the timing of writing a large insurance policy, which is substantially reinsured. Net written and net earned premium were lower in 2009 because we wrote a smaller portion of our annual Gulf of Mexico energy policies in the first quarter of 2009. We expect to write a larger portion in the second quarter of 2009. | ||
| Other specialty lines Premium decreased due to expiration of an assumed quota share contract in the second quarter of 2008 and discontinuance of a motor line written through one of our Lloyds syndicates in mid-2008. The decrease in the retention rate was due to the change in mix of business in this line. |
Three months ended March 31, | ||||||||||||||||
2009 | 2008 | |||||||||||||||
Net | Net | Net | Net | |||||||||||||
earned | loss | earned | loss | |||||||||||||
premium | ratio | premium | ratio | |||||||||||||
Diversified financial products |
$ | 214,084 | 51.8 | % | $ | 192,177 | 46.2 | % | ||||||||
Group life, accident and health |
201,088 | 74.6 | 192,446 | 74.5 | ||||||||||||
Aviation |
32,814 | 61.3 | 34,993 | 57.6 | ||||||||||||
London market account |
23,674 | 41.3 | 27,090 | 33.2 | ||||||||||||
Other specialty lines |
30,724 | 81.0 | 46,846 | 66.9 | ||||||||||||
Discontinued lines |
4 | nm | (6 | ) | nm | |||||||||||
Totals |
$ | 502,388 | 62.8 | % | $ | 493,546 | 59.4 | % | ||||||||
Expense ratio |
24.5 | 24.3 | ||||||||||||||
Combined ratio |
87.3 | % | 83.7 | % | ||||||||||||
nm Not meaningful comparison |
23
| Diversified financial products The higher net loss ratio in 2009 resulted from our increased estimation of losses on certain lines of business, particularly for our directors and officers liability and credit businesses. | ||
| Group life, accident and health While remaining flat quarter-over-quarter, the 2009 net loss ratio reflects lower losses on our medical stop-loss business, offset by adverse development and higher losses on short-term medical and other coverages. | ||
| Aviation The 2009 net loss ratio reflects higher incurred claims. | ||
| London market account The 2009 net loss ratio includes redundant reserve development on prior hurricane losses, which reduced the loss ratio 4.2 percentage points. The 2008 net loss ratio includes redundant reserve development related to our property and energy businesses, which decreased the loss ratio 10.2 percentage points. | ||
| Other specialty lines We incurred losses on our film completion and film production businesses in 2009, which increased the net loss ratio 19.7 percentage points. |
Three months ended March 31, | ||||||||
2009 | 2008 | |||||||
Net reserves for loss and loss adjustment expense payable at beginning of period |
$ | 2,416,271 | $ | 2,342,800 | ||||
Net reserve additions from acquired businesses |
30,209 | 29,053 | ||||||
Foreign currency adjustment |
(18,272 | ) | 16,100 | |||||
Incurred loss and loss adjustment expense |
315,566 | 293,026 | ||||||
Loss and loss adjustment expense payments |
(271,299 | ) | (251,624 | ) | ||||
Net reserves for loss and loss adjustment expense payable at end of period |
$ | 2,472,475 | $ | 2,429,355 | ||||
Net paid loss ratio |
54.0 | % | 51.0 | % | ||||
24
| We held $704.4 million of cash and liquid short-term investments at March 31, 2009 compared to $524.8 million at December 31, 2008. We have generated an annual average $588.2 million in cash from our operating activities, excluding cash from commutations, in the three-year period ended December 31, 2008. During the first quarter of 2009, we generated $133.6 million of cash from operating activities. | ||
| Our available for sale bond portfolio had a fair value of $4.2 billion at March 31, 2009, compared to $4.1 billion at December 31, 2008, and has an average rating of AA+. We have the intent and ability to hold these securities until their maturity but could sell some of these securities to generate cash, if the need arises; however, should we have to sell certain securities in the portfolio earlier to generate cash, given the current credit market volatility, it is possible we might not recoup the full reported fair value of the securities sold. | ||
| Our insurance companies have sufficient resources to pay potential claims in 2009, before consideration of expected cash flow from the insurance companies 2009 operations. As of December 31, 2008, we projected they will pay approximately $1.2 billion of claims and collect approximately $369.0 million of reinsurance in 2009. At December 31, 2008, they had approximately $1.0 billion of cash, short-term investments, maturing bonds, and principal payments from asset-backed and mortgage-backed securities available in 2009 to pay these claims. There has been no significant change in our expectations of their ability to pay claims as of March 31, 2009. | ||
| We have a committed line of credit, led by Wells Fargo, through a syndicate group of large domestic banks and one large foreign bank. Our Revolving Loan Facility provides borrowing capacity to $575.0 million through December 2011. At April 30, 2009, we had $275.0 million of unused capacity, which we can draw against at any time at our request. We believe that the banks will be able and willing to perform on their commitments to us. The facility agreement contains two restrictive financial covenants, with which we were in compliance at March 31, 2009. | ||
| During 2009, there have been no significant changes in either our Standby Letter of Credit Facility or our Subsidiary Lines of Credit, both of which are more fully described in our Annual Report on Form 10-K for the year ended December 31, 2008. | ||
| We may redeem all $124.7 million of our 1.30% Convertible Notes at any time. The notes are subject to conversion by the note holders should our stock exceed a set market price. Our available capacity on the Revolving Loan Facility is sufficient to cover the $124.7 million of notes outstanding at March 31, 2009 that would be due if we redeem the notes or if they are converted. Holders may next require us to repurchase the notes on April 1, 2014. | ||
| Our domestic insurance subsidiaries have the ability to pay $199.2 million in dividends in 2009 to our holding company without obtaining special permission from state regulatory authorities. Our underwriting agencies have no restrictions on the amount of dividends that can be paid to our holding company. The holding company can utilize these dividends to pay down debt, pay dividends to shareholders, fund acquisitions, repurchase common stock and pay operating expenses. Cash flow available to the holding company in 2009 is expected to be more than ample to cover the holding companys required cash disbursements. |
25
| Our debt to total capital ratio was 13.6% at March 31, 2009 and 11.5% at December 31, 2008. We have a new Universal Shelf registration statement, which was filed and became effective in March 2009 and expires in March 2012. This shelf registration statement replaces our previous one that was to expire in May 2009. The current shelf registration statement provides for the issuance of an aggregate of $1.0 billion of securities. These securities may be debt securities, equity securities, trust preferred securities, or a combination thereof. Although due to pricing we may not wish to issue securities in the current financial market, the shelf registration statement provides us the means to access the debt and equity markets relatively quickly. |
Three months ended March 31, | ||||||||
2009 | 2008 | |||||||
(as adjusted) | ||||||||
Net earnings |
$ | 83,170 | $ | 80,455 | ||||
Change in premium, claims and other receivables, net of reinsurance, other
payables and restricted cash |
(8,379 | ) | (47,431 | ) | ||||
Change in unearned premium, net |
(11,552 | ) | 2,939 | |||||
Change in loss and loss adjustment expense payable, net of reinsurance recoverables |
37,571 | 94,516 | ||||||
Change in trading portfolio |
| 9,062 | ||||||
Other, net |
32,792 | (3,741 | ) | |||||
Cash provided by operating activities |
$ | 133,602 | $ | 135,800 | ||||
March 31, 2009 | December 31, 2008 | |||||||||||||||
Amount | % | Amount | % | |||||||||||||
Short-term investments |
$ | 671,355 | 13 | % | $ | 497,477 | 10 | % | ||||||||
U.S. government and government guaranteed fixed income securities |
211,509 | 4 | 227,607 | 5 | ||||||||||||
Fixed income securities of states, municipalities and political subdivisions |
848,437 | 17 | 808,697 | 17 | ||||||||||||
Special revenue fixed income securities of states, municipalities and political subdivisions |
1,206,385 | 24 | 1,182,838 | 25 | ||||||||||||
Corporate fixed income securities |
556,185 | 11 | 511,638 | 10 | ||||||||||||
Asset-backed and mortgage-backed securities |
1,041,432 | 21 | 1,040,866 | 22 | ||||||||||||
Foreign fixed income securities |
459,102 | 9 | 485,072 | 10 | ||||||||||||
Other investments |
25,270 | 1 | 50,088 | 1 | ||||||||||||
Total investments |
$ | 5,019,675 | 100 | % | $ | 4,804,283 | 100 | % | ||||||||
26
Rating | Weighted-average life | |||
Prime
|
AA | 2.7 years | ||
Alt A
|
A | 2.9 years | ||
Subprime
|
A+ | 5.1 years |
| amount by which the securitys fair value is less than its cost, | ||
| length of time the security has been impaired, | ||
| the securitys credit rating and any recent downgrades, | ||
| stress testing of expected cash flows under various scenarios, | ||
| whether the impairment is due to an issuer-specific event, credit issues or change in market interest rates, and | ||
| our ability and intent to hold the security for a period of time sufficient to allow full recovery or until maturity. |
27
Three months ended March 31, | ||||||||
2009 | 2008 | |||||||
Average investments, at cost |
$ | 4,874,738 | $ | 4,653,910 | ||||
Net investment income * |
45,218 | 47,621 | ||||||
Average short-term yield * |
1.2 | % | 4.8 | % | ||||
Average long-term yield * |
4.3 | % | 4.4 | % | ||||
Average long-term tax equivalent yield * |
5.2 | % | 5.3 | % | ||||
Weighted-average combined tax equivalent yield * |
4.7 | % | 4.8 | % | ||||
Weighted-average maturity |
6.1 years | 6.9 years | ||||||
Weighted-average duration |
4.8 years | 5.0 years | ||||||
Average rating |
AA+ | AA+ |
* | Excluding realized and unrealized gains and losses. |
Available for Sale | Held to Maturity | |||||||||||||||
Fair Value | Amortized Cost | |||||||||||||||
Amount | % | Amount | % | |||||||||||||
AAA |
$ | 2,028,388 | 48 | % | $ | 94,744 | 100 | % | ||||||||
AA |
1,447,155 | 34 | | | ||||||||||||
A |
618,295 | 15 | | | ||||||||||||
BBB |
119,768 | 3 | | | ||||||||||||
BB and below |
14,700 | | | | ||||||||||||
Total fixed income securities |
$ | 4,228,306 | 100 | % | $ | 94,744 | 100 | % | ||||||||
| Level 1 Inputs are based on quoted prices in active markets for identical instruments. | ||
| Level 2 Inputs are based on observable market data (other than quoted prices), or are derived from or corroborated by observable market data. | ||
| Level 3 Inputs are unobservable and not corroborated by market data. |
28
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Fixed income securities |
$ | 75,839 | $ | 4,147,382 | $ | 5,085 | $ | 4,228,306 | ||||||||
Other investments |
14 | | | 14 | ||||||||||||
Other assets |
| | 16,463 | 16,463 | ||||||||||||
Total assets measured at fair value |
$ | 75,853 | $ | 4,147,382 | $ | 21,548 | $ | 4,244,783 | ||||||||
Accounts payable and accrued liabilities |
$ | | $ | (6,951 | ) | $ | | $ | (6,951 | ) | ||||||
Total liabilities measured at fair value |
$ | | $ | (6,951 | ) | $ | | $ | (6,951 | ) | ||||||
Fixed | ||||||||||||
income | Other | |||||||||||
securities | assets | Total | ||||||||||
Balance at December 31, 2008 |
$ | 6,515 | $ | 16,100 | $ | 22,615 | ||||||
Net redemptions |
(281 | ) | | (281 | ) | |||||||
Gains and (losses) unrealized |
567 | 363 | 930 | |||||||||
Gains and (losses) realized |
30 | | 30 | |||||||||
Net transfers out of Level 3 |
(1,746 | ) | | (1,746 | ) | |||||||
Balance at March 31, 2009 |
$ | 5,085 | $ | 16,463 | $ | 21,548 | ||||||
29
Three months ended March 31, 2008 | ||||||||||||
As originally | ||||||||||||
reported | As adjusted | Change | ||||||||||
Interest expense |
$ | 3,959 | $ | 4,953 | $ | 994 | ||||||
Earnings before income tax expense |
118,931 | 117,937 | (994 | ) | ||||||||
Income tax expense |
37,830 | 37,482 | (348 | ) | ||||||||
Net earnings |
81,101 | 80,455 | (646 | ) | ||||||||
Diluted earnings per share |
0.70 | 0.69 | (0.01 | ) |
December 31, 2008 | ||||||||||||
As originally | ||||||||||||
reported | As adjusted | Change | ||||||||||
Other assets (debt issuance costs and deferred tax asset) |
$ | 153,964 | $ | 153,581 | $ | (383 | ) | |||||
Notes payable |
344,714 | 343,649 | (1,065 | ) | ||||||||
Additional paid-in capital |
861,867 | 881,534 | 19,667 | |||||||||
Retained earnings |
1,696,816 | 1,677,831 | (18,985 | ) | ||||||||
Total shareholders equity |
2,639,341 | 2,640,023 | 682 |
30
31
32
Total number of | Approximate dollar | |||||||||||||||
Total | Average | shares purchased as | value of shares that | |||||||||||||
number of | price | part of publicly | may yet be | |||||||||||||
shares | paid per | announced plans or | purchased under the | |||||||||||||
Period | purchased | share | programs | plans or programs | ||||||||||||
February 1 February
28, 2009 |
200,000 | $ | 22.06 | 200,000 | $ | 32,252,353 | ||||||||||
March 1 March 31, 2009 |
1,460,000 | $ | 21.27 | 1,460,000 | $ | 1,201,217 |
10.1
|
Amended and Restated Employment Agreement effective January 1, 2007, between HCC Insurance Holdings, Inc. and Frank J. Bramanti (incorporated by reference to Exhibit 10.1 to our Form 8-K filed on December 22, 2008) | |
10.2
|
First Amendment to Employment Agreement effective December 31, 2008 between HCC Insurance Holdings, Inc. and Michael J. Schell (incorporated by reference to Exhibit 10.2 to our Form 8-K filed on December 22, 2008) | |
31.1
|
Certification by Chief Executive Officer | |
31.2
|
Certification by Chief Financial Officer | |
32.1
|
Certification with Respect to Quarterly Report |
33
HCC Insurance Holdings, Inc.
|
||||||
May 8, 2009
|
/s/ John N. Molbeck, Jr. | |||||
May 8, 2009
|
/s/ Pamela J. Penny | |||||
34